Upon successful completion of the activities, participants should be better able to:

• Review data on comorbid conditions prevalent in patients with moderate to severe psoriasis and psoriatic arthritis
• Review approved and emerging therapeutic options for the management of moderate to severe psoriasis and psoriatic arthritis
• Develop an effective treat to target strategy to manage patients with moderate to severe psoriasis
• Assess patient with psoriasis for PsA and diagnose in a timely fashion
• Describe when to refer patients with psoriasis who may have PsA to a rheumatologist
• Work in cross-functional multidisciplinary teams to manage patients with psoriasis and PsA, especially if other comorbid diseases are present

TARGET AUDIENCE
These activities are directed to dermatologists, rheumatologists, and other health care professionals involved in the treatment and management of patients with psoriatic disease.

Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)
The Cleveland Clinic Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ACTIVITY DIRECTOR

Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, Ohio

FACULTY

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio

Joseph Merola, MD
Associate Professor, Harvard Medical School
Vice Chair of Clinical Trials and Innovation, Dermatology
Director, Center for Skin and Related Musculoskeletal Diseases
Director, Clinical Unit for Research Innovation and Trials
Department of Dermatology, Department of Medicine, Division of Rheumatology
Associate Program Director, Combined Medicine-Dermatology Residency Program
Brigham and Women's Hospital
Boston, Massachusetts

REVIEWER

Sarah Young, MD
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, Ohio

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

Sarah Young, MD

Cleveland Clinic Center for Continuing Education and The France Foundation staff report no relevant financial relationships to disclose.

The Cleveland Clinic Center for Continuing Education acknowledges educational grants from:

• Amgen, Inc.
• Janssen Scientific Affairs, LLC
• Novartis Pharmaceuticals Corporation